MedPath
NMPA Approval

Valsartan and Amlodipine Tablets (II)

国药准字H20223139

March 16, 2022

Drug Information

缬沙坦氨氯地平片(Ⅱ)

片剂

每片含缬沙坦160mg,氨氯地平5mg

化学药品

March 16, 2022

Company Information

Applicant Company

上海市奉贤区海湾镇五四公路1288号

Manufacturing Company

广州高新技术产业开发区科学城开源大道11号C2栋第六层

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

缬沙坦氨氯地平片(Ⅱ) - NMPA 批准文号 | MedPath